Common Stock

In March 2017, the Board of Directors approved an increase of 555,555 Series 2 common stock. As a result, the Company’s restated certificate of incorporation, as amended, authorizes the Company to issue 19,333,333 shares of $0.0001 par value common stock, of which 6,000,000 has been designated as Series 1 common stock and 13,333,333 has been designated as Series 2 common stock. The holders of Series 1 common stock shall have no voting rights; the holders of Series 2 common stock shall have the right to one vote for each such share.

In October 2018, the Company amended and restated its certification of incorporation, which authorizes the Company to issue 100,000,000 shares of common stock and 5,000,000 shares of preferred stock, each having a par value of $0.0001. At December 31, 2018, there was no preferred stock issued and outstanding.

The holders of common stock are entitled to receive dividends whenever funds are legally available, as, when, and if declared by the Board of Directors. There have been no dividends declared to date.

The Company has reserved shares of common stock, on an issued and as-converted basis, for future issuance as follows:



	December 31, 2018	December 31, 2017
	Issued and Outstanding	Issued and Outstanding	Common Stock Equivalent Shares
Common stock	24,450,757	—	—
Series 1 common stock	—	3,112,955	3,112,955
Series 2 common stock	—	490,185	490,185
Redeemable convertible preferred stock	—	11,871,578	12,066,654
Restricted stock units outstanding	53,436	—	—
Stock options outstanding	2,641,198	3,001,929	3,001,929
Shares available for grant	2,497,082	29,654	29,654
Common stock warrants	118,122	124,326	124,326
Redeemable convertible preferred stock warrants	—	156,550	160,657
Total	29,760,595	18,787,177	18,986,360